DIN 02475812 — TARO-BUPROPION XL 300 MG
TARO-BUPROPION XL is a tablet (extended-release) of Bupropion marketed by SUN PHARMA CANADA INC. The full Bupropion monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02475812
- Brand name
- TARO-BUPROPION XL
- Active ingredient
- Bupropion
- Strength
- 300 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- SUN PHARMA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Aminoketone antidepressant (norepinephrine-dopamine reuptake inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Bupropion products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02275074 | ODAN BUPROPION SR | 100 MG | TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | MARKETED |
| 02275082 | ODAN BUPROPION SR | 150 MG | TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | MARKETED |
| 02565838 | ODAN-BUPROPION XL | 150 MG | TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | MARKETED |
| 02565846 | ODAN-BUPROPION XL | 300 MG | TABLET (EXTENDED-RELEASE) | ODAN LABORATORIESLTD | MARKETED |
| 02475804 | TARO-BUPROPION XL | 150 MG | TABLET (EXTENDED-RELEASE) | SUN PHARMA CANADA INC | MARKETED |
| 02439654 | TEVA-BUPROPION XL | 150 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02439662 | TEVA-BUPROPION XL | 300 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02237825 | WELLBUTRIN SR | 150 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | DORMANT |
| 02275090 | WELLBUTRIN XL | 150 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02275104 | WELLBUTRIN XL | 300 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |
| 02238441 | ZYBAN | 150 MG | TABLET (EXTENDED-RELEASE) | BAUSCH HEALTH, CANADA INC. | MARKETED |